EurekaMag.com logo
+ Translate

The prevalence of ureaplasma mycoplasma and antibodies against chlamydia group antigen in gynecological outpatients


, : The prevalence of ureaplasma mycoplasma and antibodies against chlamydia group antigen in gynecological outpatients. Archives of Gynecology 236(4): 203-210

Women (177) with an average age of 30 yr were investigated for ureaplasma, mycoplasma and for antibodies against the chlamydia group antigen. Specimen of endocervical mucus and catheter specimens of urine were cultured and the ELISA (enzyme-linked immunosorbent assay) technique applied. In addition the purity class (I-III) of gram-stained vaginal smears was determined. Ureaplasma were isolated from 45.8 and 26.0%, mycoplasma from 9.0 and 7.9% of cervical and urine specimens, respectively. The patients were divided into 5 clinical groups. Patients in the first 3 groups (I-III, inflammatory disorders, bleeding anomalies, benign and malignant neoplasms of the genital tract) showed a significantly (P .ltoreq. 0.05) higher colony count of ureaplasma in their urine than patients in the other 2 groups (IV and V, who had attended the hospital for reproductive problems or for routine examination). There was a clear correlation between the isolation rates of ureaplasma and mycoplasm and the purity classes of the vaginal smears. The rate of isolation increased progressively with class II and III smears. Antibodies against the chlamydia group antigen were detected in about 40% of all sera tested. A very high titer of antibodies reflecting a recent chlamydial infection was found in 11% of the sera tested.

Accession: 006740551

PMID: 4026391

DOI: 10.1007/bf02133937

Download PDF Full Text: The prevalence of ureaplasma mycoplasma and antibodies against chlamydia group antigen in gynecological outpatients


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Ikonomidis, A.; Venetis, C.; Georgantzis, D.; Giaslakiotis, V.; Kolovos, V.; Efstathiou, K.; Moschou, M.; Κoutsiaris, Ε.; Panopoulou, M., 2016: Prevalence of Chlamydia trachomatis, Ureaplasma spp., Mycoplasma genitalium and Mycoplasma hominis among outpatients in central Greece: absence of tetracycline resistance gene tet(M) over a 4-year period study. A total of 301 men and women attending local urologists and gynaecologists in the state of Thessaly, central Greece, were tested for Chlamydia trachomatis, Ureaplasma spp., Mycoplasma genitalium and Mycoplasma hominis DNA. Investigation of the tet...

Blatz, R.; Aseffa, A.; Gedefaw, M.; Rühle, H.J.; Forberg, J.; Christian, A.R., 2002: Prevalence of Chlamydia specific antibodies among obstetric and gynecological outpatients in Gondar, north-west Ethiopia. A total of 533 obstetric and gynecological outpatients who visited the dedicated clinics in Gondar, Ethiopia, between April and August 1995 were investigated for Chlamydia-specific antibodies. Relevant epidemiological and clinical data were collec...

Anonymous, 2013: Prevalence of cases of Mycoplasma hominis, Mycoplasma genitalium, Ureaplasma urealyticum and Chlamydia trachomatis in women with no gynecol. To evaluate the prevalence of Mycoplasma hominis, Mycoplasma genitalium, Ureaplasma urealyticum, Chlamydia trachomatis, Trichomonas vaginalis and Neisseria gonorrhoeae in women with no gynecologic complaints screened in the Human Reproduction outp...

Denise Maria Christofolini, Luciana Leuzzi, Fernanda Abani Mafra, Itatiana Rodart, Erika Azuma Kayaki, Bianca Bianco, Caio Parente Barbosa, 2012: Prevalence of cases of Mycoplasma hominis, Mycoplasma genitalium, Ureaplasma urealyticum and Chlamydia trachomatis in women with no gynecologic complaints. To evaluate the prevalence of <i>Mycoplasma hominis</i>, <i>Mycoplasma genitalium</i>, <i>Ureaplasma urealyticum</i>, <i>Chlamydia trachomatis</i>, <i>Trichomonas vaginalis and Neisseria gonorr...

Al-Sweih, N.A.; Al-Fadli, A.H.; Omu, A.E.; Rotimi, V.O., 2014: Prevalence of Chlamydia trachomatis, Mycoplasma hominis, Mycoplasma genitalium, and Ureaplasma urealyticum infections and seminal quality in infertile and fertile men in Kuwait. This study was undertaken to determine the prevalence of Chlamydia trachomatis, mycoplasmas, and ureaplasmas in semen samples of infertile compared with fertile men and to evaluate the seminological variables of semen from infected and noninfected...

Maeda, S-ichi.; Yasuda, M.; Ito, S.; Seike, K.; Ito, S-ichi.; Deguchi, T., 2009: Azithromycin treatment for nongonococcal urethritis negative for Chlamydia trachomatis, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum, and Ureaplasma urealyticum. Some patients with nongonococcal urethritis (NGU) are negative for Chlamydia trachomatis, mycoplasmas, and ureaplasmas. The optimal antimicrobial chemotherapy for such NGU has not fully been clarified. We assessed the efficacy of azithromycin for...

Maeda, S-Ichi.; Tamaki, M.; Kubota, Y.; Nguyen, P.Ba.; Yasuda, M.; Deguchi, T., 2007: Treatment of men with urethritis negative for Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum. Some patients with symptomatic non-gonococcal urethritis (NGU) are negative for Chlamydia trachomatis, mycoplasmas and ureaplasmas. The optimal antimicrobial chemotherapy for such NGU has not fully been elucidated, though many studies of antimicro...

Gdoura, R.; Kchaou, W.; Ammar-Keskes, L.; Chakroun, N.; Sellemi, A.; Znazen, A.; Rebai, T.; Hammami, A., 2007: Assessment of Chlamydia trachomatis, Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma hominis, and Mycoplasma genitalium in semen and first void urine specimens of asymptomatic male partners of infertile couples. The purpose of this study was threefold: to compare semen and first void urine (FVU) specimens from asymptomatic infertile men for the detection of Chlamydia trachomatis, genital ureaplasma, and genital mycoplasma infections using in-house inhibi...

Wang, Q-Yong.; Li, R-Hai.; Zheng, L-Qing.; Shang, X-Hong., 2014: Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in female outpatients, 2009-2013. The aim of this study was to estimate the prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis among female outpatients treated for genital infection at a Chinese hospital from January 1, 2009 to December 31...

Leli, C.; Mencacci, A.; Bombaci, J.Concetta.; D'Alò, F.; Farinelli, S.; Vitali, M.; Montagna, P.; Bietolini, C.; Meucci, M.; Perito, S.; Bistoni, F., 2012: Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in a population of Italian and immigrant outpatients. Ureaplasma urealyticum and Mycoplasma hominis are associated with non-gonococcal urethritis, increased risk of recurrent miscarriage, infertility and pelvic inflammatory disease. Migration flows from other countries change the local epidemiologica...